Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1145 of 5804
-
Could probiotics be the key to lowering uric acid?
Disease control Recruiting nowThe overall aim of the project is to determine whether a daily intake of health-promoting bacteria, known as probiotics, with or without a dietary fiber, affects uric acid levels in individuals with elevated levels of uric acid in the blood (hyperuricemia). Additionally, the proj…
Phase: NA • Sponsor: Örebro University, Sweden • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Experimental drug aims to shield dialysis Patients' brains
Disease control Recruiting nowCognitive decline is increasingly recognized among patients receiving maintenance hemodialysis (HD). This can include trouble remembering, slower thinking or mentally feeling foggy. This research is being done to determine if a new medication (AV-001) can protect the brain from …
Phase: PHASE2 • Sponsor: London Health Sciences Centre Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for celiac sufferers: drug targets gut damage despite strict diet
Disease control Recruiting nowThe main aim is to see how DONQ52 works to improve small intestinal damage and reduce celiac-related symptoms due to gluten exposure, in participants with celiac disease (CeD) attempting to maintain a gluten-free diet (GFD) in treated participants versus placebo controls.
Phase: PHASE2 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New drug MK-4716 targets KRAS cancers in early trial
Disease control Recruiting nowResearchers are looking for new ways to treat certain advanced or metastatic solid tumors. The goal of this study is to learn about the safety of MK-4716 and if people tolerate it when taken alone or with other treatments.
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for painful skin condition: experimental drug enters mid-stage trial
Disease control Recruiting nowThe purpose of this study is to assess efficacy, safety, pharmacokinetics and immunogenicity of subcutaneous SCT650C in patients with Moderate to Severe Hidradenitis Suppurativa
Phase: PHASE2 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
AI reads CT scans to tell old from new spine breaks
Diagnosis Not yet recruitingOsteoporotic vertebral compression fractures are common in older adults and may present as either acute or chronic fractures. Correctly distinguishing acute from chronic fractures is clinically important because treatment strategies and management decisions differ depending on fr…
Sponsor: Xin Fan • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Freezing nerves during lung transplant could cut opioid use
Symptom relief Recruiting nowThis study is testing a new way to help manage pain after a double lung transplant. Instead of relying only on strong pain medicines like opioids, doctors will use a cold-therapy probe during surgery to help numb the nerves near the incision. Researchers want to see if this metho…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New drug cocktail aims to shrink colorectal tumors
Disease control Recruiting nowThe FUTURE trial is a prospective, multicentre, exploratory, open-label phase II platform trial. Its goal is to evaluate the efficacy, feasibility and safety of futibatinib combined with immunotherapeutic, targeted or chemotherapeutic agents in colorectal and other solid tumors a…
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Herbal drink may soothe radiation mouth pain in cancer patients
Symptom relief Recruiting nowTo explore the efficacy of Houyanqing Oral Liquid combined with conventional treatment in preventing and treating radiation-induced oral mucositis, so as to improve the quality of life of nasopharyngeal carcinoma patients received radiotherapy.
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Zapping the brain to ease Parkinson's slowness
Symptom relief Recruiting nowThis study investigates the use of patterned repetitive transcranial magnetic stimulation (prTMS) as an intervention for bradykinesia in Parkinson's Disease (PD). More specifically, the study aims to determine whether prTMS over the supplementary motor area (SMA) can reduce sever…
Phase: NA • Sponsor: Danish Research Centre for Magnetic Resonance • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Can a simple drug stop bleeding in stem cell patients?
Disease control Recruiting nowThis study employs a prospective, randomized, double-blind, placebo-controlled design. It aims to compare the efficacy of etamsylate versus placebo in preventing bleeding complications in patients with thrombocytopenia following hematopoietic stem cell transplantation.
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New study tests best way to prevent second stroke in seniors with a hole in the heart
Disease control Recruiting nowPatent foramen ovale (PFO) is an important mechanism of embolic stroke of undetermined source (ESUS). Current guidelines recommend PFO closure for high-risk PFO in patients younger than 60 years, and a recent retrospective cohort study from Taichung Veterans General Hospital has …
Sponsor: Taichung Veterans General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug combo targets fatty liver in major trial
Disease control Recruiting nowThe primary objective of this trial is to evaluate the dose-dependent and comparative effects of ECC4703 (low and high dose), ECC0509 (low and high dose), and their combination on hepatic fat reduction as assessed by change in magnetic resonance imaging proton density fat fractio…
Phase: PHASE2 • Sponsor: Eccogene • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New shingles pain pill shows promise in major trial
Symptom relief Recruiting nowHerpes zoster (HZ) is characterized by a painful dermatomal rash and significantly affects quality of life, with acute pain increasing the risk of postherpetic neuralgia. Although early antiviral therapy limits viral replication, its analgesic effect is insufficient, and many pat…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Minty relief? menthol gel tested for Parkinson's symptoms
Symptom relief Not yet recruitingParkinson's disease (PD) is a progressive neurological disorder characterized by both motor and non-motor symptoms due to the degeneration of dopamine-producing neurons. There is currently no cure. Menthol, a natural compound that activates TRPM8 receptors, has shown neuroprotect…
Phase: PHASE2 • Sponsor: Taipei Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Can oxygen chambers boost heart failure treatment?
Disease control Not yet recruitingThis study aims to investigate whether adjunctive hyperbaric oxygen therapy, compared to guideline-directed medical therapy with the "New Four Pillars" (ARNI/ACEI/ARB + β-blocker + MRA + SGLT2 inhibitor) alone, improves cardiac function in patients with chronic heart failure, and…
Phase: NA • Sponsor: Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could fenofibrate be a Game-Changer for PBC patients?
Disease control Recruiting nowThe goal of this clinical trial is to learn if the drug Fenofibrate works to treat adults with a liver disease called Primary Biliary Cholangitis (PBC) who have not received previous treatment. It will also learn about the safety of Fenofibrate. The main questions it aims to answ…
Phase: PHASE3 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Balloon trick during cancer surgery may prevent stomach troubles
Disease control Recruiting nowBackground: Esophageal carcinoma ranks among the most common and lethal cancers worldwide. Minimally invasive esophagectomy is the standard curative treatment, but postoperative delayed gastric conduit emptying (DGCE) remains a major complication, occurring in up to 40% of patie…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New immunotherapy combo targets High-Risk prostate cancer before and after surgery
Disease control TerminatedThis Phase 2 clinical trial is testing a new immunotherapy combination (N-803, ETBX-071, M-CENK) for men with high-risk prostate cancer before and after prostate surgery. The goal is to see if this treatment improves cancer outcomes and is safe.
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug AZD1163 aims to ease rheumatoid arthritis pain
Disease control Recruiting nowPhase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC